SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-062867
Filing Date
2018-12-03
Accepted
2018-12-03 16:12:02
Documents
3
Period of Report
2018-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv508378_8k.htm 8-K 29930
2 EXHIBIT 10.2 tv508378_ex10-2.htm EX-10.2 26878
3 EXHIBIT 10.3 tv508378_ex10-3.htm EX-10.3 113790
  Complete submission text file 0001144204-18-062867.txt   172119
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 181214142
SIC: 2834 Pharmaceutical Preparations